Related Experiment Video

Updated: Jun 5, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

A mammalian functional-genetic approach to characterizing cancer therapeutics

Hai Jiang1, Justin R Pritchard, Richard T Williams

  • 1The Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Nature Chemical Biology
|December 28, 2010
PubMed

Insights

This study introduces an RNA interference (RNAi) strategy using short hairpin RNAs (shRNAs) to identify drug mechanisms. This method accurately groups chemotherapeutics and predicts actions of new anticancer drugs.

Area of Science:

  • Molecular Biology
  • Pharmacology
  • Genomics

Background:

  • Determining drug mechanisms is crucial for developing effective chemotherapeutics.
  • Current methods for characterizing small-molecule function are often limited.

Purpose of the Study:

  • To develop and validate an RNA interference (RNAi)-based strategy for characterizing small-molecule function in mammalian cells.
  • To create a predictive model for identifying mechanisms of action for novel chemotherapeutics.

Main Methods:

  • Utilized RNA interference (RNAi) by expressing short hairpin RNAs (shRNAs) in mammalian cells.
  • Assessed cellular responses to a diverse set of chemotherapeutics.
  • Generated functional shRNA signatures to group drugs by biochemical modes of action.
  • Employed a probability-based nearest-neighbors approach for prediction.

Main Results:

  • Successfully grouped drugs into established biochemical modes of action based on shRNA signatures.
  • Developed a high-resolution prediction method for mechanisms of action of poorly characterized small molecules.
  • Reduced the predictive shRNA target set to as few as eight genes.
  • Extended predictive power to characterize additional drug categories.

Conclusions:

  • A focused shRNA phenotypic signature offers a sensitive and tractable approach for characterizing new anticancer drugs.
  • This RNAi-based strategy significantly advances the identification of drug mechanisms.
  • The method facilitates the development and effective use of chemotherapeutics.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...